Florida’s medical cannabis market generated $151,751,564 in sales in January, marking a notable increase from the $142 million recorded in December and the $145 million sold in January 2025, according to data from the research firm Headset.
The January figure continues a pattern of steady sales for what remains the largest medical-only marijuana market in the country in terms of overall revenue and patient count (Oakland has more licensed dispensaries). Flower continued to account for the largest share of spending, representing about 46% of total sales. Vaporizers and vape pens followed at roughly 24%, while edibles and concentrates each made up 11% and 9% respectively. Pre-rolls represented around 5% of the market and capsules and tinctures both at about 2%. About .5% of sales were topicals.
Data from the Florida Department of Health shows the state’s medical marijuana program now serves 932,747 registered patients across over 740 operating dispensaries as of January 30, 2026.
In 2025, medical cannabis sales surpassed $1.6 billion, a slight decrease from 2024’s total. Many analysts attributed the decrease to the rise in popularity of intoxicating hemp products, which can be purchased online and in many gas stations and convenient stores without needing to obtain or renew a medical cannabis card. Despite the popularity of hemp-derived cannabinoid products, the state’s medical cannabis market remains massive, with only a few recreational cannabis states having more monthly sales.
More articles from The Marijuana Herald:
